title: Bosentan improves systemic sclerosis-related peripheral circulation insufficiency.
authors.forename: Shusuke
authors.initials: S
authors.lastname: Yagi
authors.forename: Masashi
authors.initials: M
authors.lastname: Akaike
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Aihara
authors.forename: Takashi
authors.initials: T
authors.lastname: Iwase
authors.forename: Yuka
authors.initials: Y
authors.lastname: Sumitomo-Ueda
authors.forename: Sumiko
authors.initials: S
authors.lastname: Yoshida
authors.forename: Toshio
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Masataka
authors.initials: M
authors.lastname: Sata
mesh_terms: D000328:Adult; D000368:Aged; D001775:Blood Circulation / Q000187:drug effects* / Q000502:physiology; D000077300:Bosentan; D005260:Female; D006801:Humans; D008875:Middle Aged; D010147:Pain Measurement / Q000187:drug effects; D011928:Raynaud Disease / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D013449:Sulfonamides; D000077300:Bosentan